EX1
Click for more information
0.57% 87.5¢ exopharm limited

Ann: Positive outcomes in first animal study involving Plexaris

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    05/02/19
    08:59
    Post #: 37330023
    • Release Date: 05/02/19 08:39
    • Summary: Positive outcomes in first animal study involving Plexaris
    • Price Sensitive: Yes
    • Download Document    Not available as of the moment.
    Likes Created with Sketch. 4  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add EX1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.